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Distinctive features of lincRNA gene expression suggest
widespread RNA-independent functions
Alex C Tuck1,3 , Kedar Nath Natarajan3,4,6,*, Greggory M Rice5,*, Jason Borawski5, Fabio Mohn1, Aneliya Rankova1,2,
Matyas Flemr1, Alice Wenger1, Razvan Nutiu5, Sarah Teichmann3,4 , Marc Bühler1,2
Eukaryotic genomes produce RNAs lacking protein-coding po-
tential, with enigmatic roles. We integrated three approaches to
study large intervening noncoding RNA (lincRNA) gene functions.
First, we proﬁled mouse embryonic stem cells and neural pre-
cursor cells at single-cell resolution, revealing lincRNAs expressed in
speciﬁc cell types, cell subpopulations, or cell cycle stages. Second,
we assembled a transcriptome-wide atlas of nuclear lincRNA deg-
radation by identifying targets of the exosome cofactor Mtr4. Third,
we developed a reversible depletion system to separate the role of
a lincRNA gene from that of its RNA. Our approach distinguished
lincRNA loci functioning in trans from those modulating local gene
expression. Some genes express stable and/or abundant lincRNAs in
single cells, but many prematurely terminate transcription and
produce lincRNAs rapidly degraded by the nuclear exosome. This
suggests that besides RNA-dependent functions, lincRNA loci act as
DNA elements or through transcription. Our integrative approach
helps distinguish these mechanisms.
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Introduction
Eukaryotic genomes are pervasively transcribed by RNA polymerase
II (Pol II), producing many long non-protein-coding RNAs (lncRNAs)
in addition to mRNAs (Kapranov et al, 2002). LncRNAs are classiﬁed
by their genomic origins, which include independent transcription
units (large intervening noncoding RNAs [lincRNAs]) (Guttman et al,
2009), regions upstream of protein-coding genes (promoter up-
stream transcripts [PROMPTs] [Preker et al, 2008]) and enhancers
(enhancer RNAs).
The biological signiﬁcance of lncRNAs is strongly debated (Palazzo
& Lee, 2015; Deveson et al, 2017), with key questions (i) how many
lncRNAs are functionally relevant, (ii) what are the activities of
lncRNAs, and (iii) what are the underlying mechanisms? Reported
lncRNA functions include many cases where the transcript itself is
important (e.g., Xist or Fendrr [Grote et al, 2013; Chu et al, 2015]) and
some cases where the RNA product is superﬂuous, but the act of
transcription (e.g., Airn [Latos et al, 2012]) or the underlying DNA
element (e.g., Bendr or Lockd [Engreitz et al, 2016; Paralkar et al, 2016])
affects local gene expression.
Of the various lncRNA classes, lincRNAs have most properties in
common with mRNAs, including a 59 m7G cap, poly(A) tail and
regulation by key transcription factors (Guttman et al, 2009). As
lincRNAs are enriched in the nucleus (relative to mRNAs) (Engreitz
et al, 2016), they are primarily suggested to regulate gene ex-
pression. This regulation might occur in cis (involving adjacent
genomic loci) or in trans (involving distant, unlinked target genes).
LincRNAs are highly differentially expressed between cell types
(Cabili et al, 2011) and many have been shown to help specify cell
type by acting as functional RNAs (Guttman et al, 2009; Grote et al,
2013; Lin et al, 2014; Leucci et al, 2016). On the other hand, some
lincRNA genes could function as DNA elements or via transcription
without the need for RNA itself (Engreitz et al, 2016; Ard et al, 2017;
Joung et al, 2017). In support of this, lincRNAs are less efﬁciently
spliced than mRNAs and differ in some aspects of 39 end formation
(Mele´ et al, 2017; Schlackow et al, 2017). Furthermore, some reports
suggest that lincRNAs have half-lives similar to mRNAs and are
highly expressed in individual “jackpot” cells, whereas others
conclude that lincRNAs are less stable and ubiquitously lowly
expressed, fuelling the debate of whether the RNA itself is func-
tional (Cabili et al, 2015; Liu et al, 2016; Mele´ et al, 2017; Schlackow
et al, 2017). New approaches must, therefore, identify which lincRNA
genes are functionally important and distinguish whether they
function as DNA elements, by transcription, or via the RNA product
(Bassett et al, 2014).
Two broad strategies are currently used to search for functional
lincRNA genes. The ﬁrst makes predictions based on the properties of
the gene or the RNA product, including tissue- or cell type–speciﬁc
expression, co-expressionwith other genes, evolutionary conservation,
subcellular localisation, or RNA processing and stability (Guttman et al,
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2010; Tuck & Tollervey, 2013; Necsulea et al, 2014; Cabili et al, 2015). The
second uses forward genetic screening to identify lincRNA genes
important for a particular phenotype, via targeted or large-scale gene
deletions (Sauvageau et al, 2013; Zhu et al, 2016), promoter deletions
(Engreitz et al, 2016), integrations of poly(A) cassettes to prematurely
terminate transcription (Latos et al, 2012; Engreitz et al, 2016), or CRISPR
interference or activation to down- or up-regulate transcription (Joung
et al, 2017; Liu et al, 2017).
Approaches to identify functional lincRNA genes are rapidly
improving in potency and ease of use. For example, direct RNA-
targeting approaches using antisense oligonucleotides (ASOs)
(Leucci et al, 2016) or CRISPR-Cas13 (Abudayyeh et al, 2017; Cox et al,
2017) can now efﬁciently knock down lincRNA expression to directly
test the role of the RNA product. This was not the case with previous
approaches, such as gene deletion or CRISPR interference, that
alter DNA sequence and/or transcription and suffer from un-
predictable consequences such as the initiation of novel tran-
scripts (Howe et al, 2017). Despite these recent advances, the
efﬁcacy of lincRNA knockdowns can be variable, and there may be
off-target effects. Further improvements to these methods, and the
testing of additional strategies, is therefore necessary to obtain rapid,
efﬁcient, long-lived, and reversible systems to directly target lincRNAs.
With the above considerations in mind, we sought to address
three key challenges to understanding lincRNA gene functions
(Bassett et al, 2014): (i) to predict which lincRNA genes might be
functionally relevant, (ii) to experimentally test whether these
genes function in cis or in trans and whether the RNA product is
required for this, and (iii) to more broadly assess the properties of
lincRNA transcripts, to help understand how many lincRNA genes
produce a functional RNA, versus how many might instead function
as DNA elements or via the act of transcription.
To address these aims, we proﬁled mouse embryonic stem cells
(mESCs) and derived neural precursor cells (NPCs) using both
single-cell and bulk RNA sequencing. We identiﬁed lincRNAs with
notable cell type– or subpopulation-speciﬁc expression and pre-
dicted functionally relevant lincRNA genes. Focusing on 16 of the
most promising lincRNA genes, we generated cell lines in which
these loci were deleted. In parallel, we developed a self-cleaving
ribozyme approach to deplete the expression of some of these
lincRNA transcripts, while minimising disruption to the lincRNA
gene (i.e., to test the function of the RNA product). Overall, our in-
depth analyses of 140 cell lines highlight two key aspects. First,
although many lincRNA genes function in trans, we predict that up
to a third of lincRNA loci act in cis to modulate the expression of
neighbouring genes. Second, the RNA product may not be required
for these local lincRNA gene activities. To investigate this further, we
examined lincRNA properties. We proﬁled the transcriptome-wide
direct targets of the nuclear exosome, ﬁnding that in contrast to
mRNAs, most lincRNAs prematurely terminate transcription (within
a few hundred nucleotides of their promoter) and are rapidly targeted
for degradation. These properties support recent suggestions that
functional lincRNA genes might commonly act as DNA elements or
through transcription, without requiring the RNA (Engreitz et al, 2016;
Paralkar et al, 2016; Joung et al, 2017) and underscore the importance of
directly testing the role of the RNA product.
In summary, our study unravels key differences between lincRNA
and mRNA behaviours and provides a comprehensive resource to
predict and experimentally test lincRNA gene functions and in
particular the role of the RNA product.
Results
An atlas of lincRNA expression in mESCs and NPCs at single-cell
resolution
To identify lincRNA genes that might contribute to cell identity, we
generated an atlas of lincRNA expression across a differentiation
time course from mESCs to NPCs using both single-cell and bulk
RNA sequencing. We selected this model system because many
lincRNAs are expressed and a robust in vitro differentiation pro-
tocol exists (Bibel et al, 2004; Wu et al, 2010). Furthermore, a recent
screen found that in humans, lincRNA-dependent growth pheno-
types are most readily detected in stem cells (Macfarlan et al, 2012),
highlighting them as an excellent model system.
We performed strand-speciﬁc, rRNA-depleted total RNA-seq for
two biological replicates each of mESCs grown in 2i + LIF medium,
mESCs grown in serum + LIF (leukemia-inhibitory factor) medium, and
during days 3, 6, and 8 of the in vitro NPC differentiation. To obtain
a single, comprehensive catalogue of lincRNA genes, we combined
a de novo transcript assembly from our data with published lincRNA
coordinates (Guttman et al., 2009, 2010; Necsulea et al, 2014) and
Ensembl annotations. After ﬁltering the initial set of 7,333 putative
lincRNAs for a minimal expression level in at least one of the proﬁled
conditions (>10 reads per kilobase), repeat content (<50%), and no
overlap or proximity (<5 kb) to protein-coding genes, we obtained 1,721
high-conﬁdence lincRNAs (Table S1A, “high.quality.biotype” column).
Expression of many lincRNAs (such as linc1503) was modulated
during neuronal differentiation (Fig 1A and B, and Table S2), sug-
gesting that they are regulated in a cell type–speciﬁc manner and
might contribute to specifying cell fate. Based on this analysis, we
began to shortlist lincRNA genes for functional characterisation in
ES cells, considering additional criteria such as robust expression,
functional evidence from previous studies (Guttman et al, 2009;
Bergmann et al, 2015), and lack of protein-coding capacity based on
ribosome proﬁling data or computational predictions (Chung et al,
2015; Sun et al, 2015) (Tables 1 and S1).
LincRNAs are known to be less expressed than mRNAs (as we
also see, Fig 1C), which can either be due to a homogenous low
expression or a high abundance in small subpopulations of cells.
Furthermore, mESC and NPC cell cultures are heterogeneous, and
lincRNAs may be differentially expressed between subpopulations of
cells. To explore these issues further, we performed single-cell RNA
sequencing of batch-matched cells from the mESC to NPC differen-
tiation using SMART-Seq on the Fluidigm C1 System. After quality
control, which 469 cells passed (Fig S1A), variance and clustering
analyses on the scRNA-seq data clearly separated the cell states and
captured the differentiation trajectory, in good agreement with the
bulk RNA-seq andwith the expected changes in ESC andNPCmarkers
(Figs 1D and E, and S1C). In addition, subpopulations of mESCs and
NPCs expressing speciﬁc combinations of genes were apparent
(Fig 1E). For example, we clearly resolved three subpopulations of
serum + LIF mESCs with different combinations of Oct4 and Nanog
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expression, corresponding to previously reported “pluripotent,”
“differentiation permissive,” and “committed to differentiation”
subpopulations (enlarged in Fig 1F) (Kolodziejczyk et al, 2015).
LincRNAs (including linc1333 and lincRNA_2485, which we high-
light later) are differentially expressed between these three (and
other) subpopulations (listed in Fig S1B). Therefore, the single-
cell data reveal an additional layer of complexity in lincRNA
expression beyond that seen with bulk RNA-seq analysis.
Remarkably, repeating the single-cell clustering using only
lincRNAs (listed in Table S1B) was sufﬁcient to resolve cell types
(Fig 2A) and conﬁrmed the lincRNA dynamics detected in the bulk
RNA-seq (Fig 1A). Having veriﬁed the quality of the single-cell RNA-
seq data, we next addressed the question about heterogeneity of
lincRNA expression. To this end, we used two approaches to
identify lincRNAs expressed across cell subpopulations. First, we
measured cell-to-cell variation for all transcripts by calculating the
distance to the median (DM), enabling us to identify highly variably
expressed lincRNAs (Fig 2B) (Kolodziejczyk et al, 2015). Second, we
mined for individual “jackpot” cells, where lincRNA expression was
much higher than the population median (Fig 2C).
We anticipated lincRNAs to be more heterogeneously expressed
than mRNAs across single cells (as reported in Liu et al [2016]).
Figure 1. Single-cell atlas of lincRNA expression
during mESC to NPC differentiation.
(A) Bulk RNA-seq heat map of differentially expressed
mRNAs and lincRNAs in mESCs grown in 2i + LIF
medium, mESCs grown in serum + LIF medium, or
derived NPCs. Black bars on the left indicate lincRNAs,
and lincRNAs explored in this study are labelled on the
right. The 2,000 genes with highest variance were
selected. (B) An example of a lincRNA with strong
differential expression (bulk RNA-seq) during mESC to
NPC differentiation. (C) LincRNA and mRNA expression
distributions from bulk RNA-seq analysis of mESCs
(serum + LIF). (D) Two-dimensional t-SNE (t-Distributed
Stochastic Neighbor Embedding) projection of single
cells during mESC to NPC differentiation, coloured by
sample (“cell annotations”) or the expression of
marker genes. (E) Heat map showing the most variably
expressed mRNAs and lincRNAs during mESC to NPC
differentiation (rows), across single cells (columns).
Protein-coding genes encoding stem cell, neuronal, or
cell cycle factors are highlighted (green, blue, and
violet bars), as are lincRNAs (black bars). LincRNAs
selected for further study are indicated by red bars.
(F) Magniﬁed view of the highlighted region (red
rectangle) from (E), revealing subpopulations of serum
+ LIF mESCs with characteristic expression of
pluripotency markers (rows indicated with orange
labels) and lincRNAs (rows indicated with black bars).
Previously reported subpopulations are indicated
(columns highlighted by green bars underneath). See
also Fig S1 and Table S1A.
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However, we only observed minor class-wide differences between
lincRNAs and mRNAs (Fig 2B and C), which held true across all
expression levels. In this respect, our transcriptome-wide results
concur with a smaller scale microscopy study of 61 lincRNAs (Cabili
et al, 2015). Therefore, in general, the lower average abundance of
lincRNAs compared with mRNAs arises from lower expression
across all cells, rather than highly subpopulation-restricted
expression. That is not to say that lincRNAs are homogenously
expressed, but simply that both lincRNAs and mRNAs exhibit
similar amounts of heterogeneity. Indeed, we found lincRNAs
that were highly variably expressed across single cells (e.g., Pvt1,
Fig 2D), just as we found lincRNAs that were more uniformly
expressed (e.g., linc1333, Fig 2E). LincRNAs such as Pvt1 that accu-
mulate to high levels in “jackpot cells” may function in speciﬁc
subpopulations of cells.
The variability in lincRNA expression across single cells enabled
us to explore in depth the gene regulatory networks within which
lincRNA genes might act during differentiation. First, we calculated
pairwise correlation coefﬁcients based on single-cell RNA-seq gene
expression. We identiﬁed ~60,000 signiﬁcant correlations (Table S3)
between 113 lincRNA and ~3,600 protein-coding genes (e.g., linc1509
correlations, Fig 2F). This provides a rich resource to explore which
factors might regulate lincRNA expression and which genes are
potentially regulated by lincRNAs. For example, this analysis revealed
that Pvt1 “jackpot cells” also express high levels of Nmnat2 and Zic3
(Fig S1D). Intriguingly, these genes are up-regulated in cancers
exhibiting high Pvt1 expression, suggesting that this gene expression
module may commonly be up-regulated in highly proliferating cell
populations (Cui et al, 2016; Rao et al, 2017). Second, we investigated
whether some of the variability in lincRNA levels might arise from cell
cycle stage–speciﬁc expression. For this, we used the NPC data, as cell
cycle stages based onmarker expressionweremore clearly resolved in
NPCs (Fig 2G) than in mESCs, which have an unusually short G1 phase.
We found examples of lincRNAs speciﬁcally expressed during G1/S
(e.g., XLOC_071380, ~50 kb from theHoxC cluster) or G2/M (e.g.,Miat and
Rmst) (Fig 2G). Notably,Miat was previously implicated in cell cycle
regulation (Yi et al, 2017). Therefore, our data reveal lincRNAs
expressed in cell subpopulations deﬁned by numerous factors,








These lincRNAs were selected based on the
following criteria
XLOC_004770 NA 129 1 linc1251/Platr7 ESC speciﬁc; reported to be associated withpluripotency
XLOC_023375 NA 57 1 linc1503 ESC speciﬁc
XLOC_046670 0.6 78 5 linc1400 ESC speciﬁc
XLOC_011841 0.2 1,950 90 linc1283/lncEnc1 ESC speciﬁc; required for ESC colony formation
XLOC_017240 0.2 352 31 linc1296 ESC speciﬁc
XLOC_021390 0.5 117 2 — ESC speciﬁc
XLOC_023934 0.4 97 3 — ESC speciﬁc
XLOC_029998 0.4 493 57 linc1333/Platr4
ESC speciﬁc; reported to be required for
pluripotency
XLOC_049334 0.3 132 4 linc1405/Platr11
ESC speciﬁc; reported to be required for
pluripotency
XLOC_018267 0.5 141 4 linc1611 ESC speciﬁc
XLOC_025367 0.1 600 47 linc1509 ESC speciﬁc; reported to be required forpluripotency
XLOC_009546 NA 25 1 Tuna ESC speciﬁc; reported to be required forpluripotency
XLOC_051383 0.1 608 728 linc1409/Firre Widely expressed; reported to regulate chromatincontacts
XLOC_035805 0.2 97 102 linc1543 Widely expressed; syntenic with humanpluripotency lincRNA
XLOC_015936 NA 34 23 linc1476/Pvt1 Widely expressed, with very high levels in somemESCs; oncogene
XLOC_036848 NA 180 4,370 Miat Elevated in NPCs; expressed during speciﬁc cellcycle stages
Gene IDs are deﬁned as in Table S1 (from the combined set of published and ab initio lincRNA/mRNA annotations). For translation efﬁciency, NA = could not be
calculated, and for comparison, the median value for mRNAs is 1.0. Expression values in mESCs and derived NPCs were calculated using bulk RNA-seq data,
normalising with the DESeq2 size factor function, and averaging the results from the two cell lines we tested (BC8 and CB9). Previously reported names for the
lincRNAs are indicated, as well as notable features that we considered when shortlisting these lincRNAs (ESC-speciﬁc expression is deﬁned using our RNA-seq
data) (Guttman et al, 2009; Hacisuleyman et al, 2014; Jain et al, 2016; Lin et al, 2014; Bergmann et al, 2015).
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including pluripotency and neural markers, and cell cycle stages,
hinting at potential functions of these lincRNA genes.
In summary, our integrated bulk and single-cell RNA-seq analysis
provides a comprehensive catalogue of 1721 lincRNAs detected during
mESC to NPC differentiation (Tables S1 and S2). We classify lincRNAs
expressed speciﬁcally in mESCs, NPCs, and/or across subpopulations
of cells or during speciﬁc cell cycle stages and explore the potential of
these lincRNA genes to participate in gene regulatory networks (Table S3).
Ultimately, however, such computational predictions must be
tested. Therefore, based on these analyses, we prioritised 16 lincRNA
genes expressed in mESCs that we now sought to investigate exper-
imentally (Table 1).
Ribozymes: new tools to investigate lincRNAs
We wanted to rigorously test the functions of our shortlisted lincRNA
genes (Table 1) and to investigate whether the RNA itself is functional
or whether the DNA locus or its transcription is more important
(Bassett et al, 2014). To this end, we tested a new method to deplete
lincRNA transcripts, without signiﬁcantly affecting the DNA locus.
Figure 2. LincRNAs expressed in speciﬁc
subpopulations of mESCs and NPCs.
(A) Expression of highly variable lincRNAs (rows; listed
in Table S1B) in single cells (columns), clustered by
lincRNA expression. Cell types (mESCs in 2i + LIF or
serum + LIF, and day 6 and 8 NPCs) and cell cycle stages
(assigned by clustering on cell cycle marker gene
expression) are indicated at the top. (B) Cell-to-cell
variation in expression for mRNAs (grey) and lincRNAs
(red), across mESCs (top), or NPCs (bottom), quantiﬁed
using the DM method (Kolodziejczyk et al, 2015). The
median DMs for lincRNAs and mRNAs are listed, and
the distributions tested for similarity using the
Wilcoxon rank sum test. (C) Scatter plot comparing the
90th expression percentile across single cells versus
the median expression, for each lincRNA (red) and
mRNA (grey). (D, E) Single cell expression pattern of
a highly variable mESC lincRNA (D, Pvt1) and
a uniformly expressed mESC lincRNA (E, linc1333),
overlaid on the t-SNE projection. (F) An example of
correlated lincRNA-mRNA single cell expression across
mESC to NPC differentiation, with cells ordered by
pseudotime determined using Monocle (Trapnell et al,
2014). (G) Top panels: cell cycle stage assignments for
day 8 NPCs based on single cell expression of marker
genes (Kolodziejczyk et al, 2015). Bottom panels:
examples of three lincRNAs expressed during speciﬁc
cell cycle stages (XLOC_071380 = G1/S enriched, and
Miat and Rmst = G2/M enriched). For each lincRNA, the
heat bars show expression levels across the 67 G1/S cells
(top bar) and 48 G2/M cells (bottom bar). In (B, C), key
lincRNAs selected for detailed exploration are highlighted
in green. See also Fig S1 and Tables S1A, B, and S3.
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Our method is simple and relies only on the stable integration of
a 52-nt self-cleaving ribozyme sequence into a lincRNA gene using
CRISPR-Cas9. Following transcription, the lincRNA transcript is
cleaved and ultimately degraded. Our approach has several ad-
vantages: (i) it targets lincRNA transcripts with minimal perturba-
tion to the DNA locus, which can additionally be controlled with an
inactive point mutant ribozyme, (ii) it knocks down nuclear targets,
(iii) it can be used to study long-duration processes such as cell
differentiation, (iv) it does not suffer from nonspeciﬁc and off-
target effects, and (v) it can be reversed with a blocking ASO to
rescue lincRNA expression.
We initially tested two ribozymes, the Hammerhead (HHRz) and
Hepatitis Delta virus (HDVRz), for their ability to cleave different
reporter constructs (Figs 3A and S2A) (Camblong et al, 2009; Nomura
et al, 2013). For the HDVRz, we also tested inducible versions
(aptazymes, HDVAz) that fold and cleave upon guanine addition
(Nomura et al, 2013), and different HDVAz ﬂanking sequences that
suppress background cleavage (without guanine). However, these
were less efﬁcient than the HHRz (Fig S2A and B). As a proof of
principle, we then knocked down the expression of an endogenous
protein-coding gene, G9a, by homozygous integration of the HHRz
(Fig 3B). The HHRz reduced G9a expression by up to 81% across four
different cell lines (versus ﬁve controls), resulting in widespread
gene expression changes of known G9a targets (Macfarlan et al,
2012), as measured by bulk RNA-seq (Fig 3C and D). This conﬁrms
that the ribozyme approach can be used to identify cases where
a gene functions via its RNA product.
We next systematically knocked down the expression of 15
candidate lincRNA genes by genomic integration of the HHRz (guide
RNAs are highlighted in red in Table S5), obtaining between two and
eight biological replicates for each gene, and assessed knockdown
efﬁciency by RNA-seq (Fig 4A) and in some cases by qPCR (Fig S2C).
We identiﬁed a range of knockdown efﬁciencies for lincRNA targets
with various stabilities and expression levels (>80% knockdown for
linc1405, linc1509, and linc1611) (Fig 4A). The inefﬁcient knockdowns
(e.g., of Pvt1, linc1251, and Firre) could be due to the sequence
context of the tested site impeding ribozyme folding. Inclusion of
a ﬂanking insulator sequence (see the Materials and Methods
section) might help for these genes, or an alternative strategy (e.g.,
ASOs or the HDVRz/Az) could be tested. Importantly, our method
can destabilise nuclear transcripts such as linc1405 and linc1509
(Engreitz et al, 2016), supported by a reduction in linc1509 intron
(= pre-lincRNA) levels (Fig 4A and B).
A stable knockdown can highlight the impact of lincRNA tran-
scripts on steady-state gene expression and/or across temporal
processes (e.g., differentiation or development). However, lincRNAs
might perform transient roles affecting cell state and transitions.
Furthermore, some lincRNAs exhibit high variability in expression
Figure 3. Development of a ribozyme method to
knock down RNA expression.
(A) Plasmid-based ﬂuorescent reporter assay to test
RNA knock down by the Hammerhead ribozyme. The
HHRz, or an inactive point mutant, was placed between
GFP and RFP ORFs, and the relative ﬂuorescence
intensity measured (bar chart, right) to quantify
cleavage efﬁciency. Statistical signiﬁcance was tested
using a two-tailed t test, comparing with the wild-type
cell line. Mean ± SD is shown (n = 192 technical
replicates). (B) Assessment of knockdown of
endogenous G9a mRNA levels upon genomic
integration of an HHRz cassette into the 39 UTR of G9a.
RNA levels were quantiﬁed by RT–qPCR and
normalised to TBP. Statistical signiﬁcance was tested
using a two-tailed t test, comparing with all wild-type
cell lines. Mean ± SD is shown (n = 3 technical
replicates). (C) PCA to assess the gene expression
pattern in four G9a HHRz cell lines (green) relative
to 136 cell lines with a wild-type G9a locus (grey).
(D) Differential expression analysis of G9a HHRz
knockdown cell lines, with signiﬁcantly differentially
expressed genes highlighted in red (DESeq2 adjusted
P < 0.05), and signiﬁcantly up-regulated genes also up-
regulated in a previous study of G9a knockdown cells
highlighted in green (Macfarlan et al, 2012). See also Fig S2.
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between clonal cell lines (in part due to their low expression levels),
which make comparisons of wild-type and knockdown cell lines
challenging and demands many biological replicates. We therefore
sought to inhibit HHRz cleavage in our cell lines to rapidly rescue
lincRNA levels and thus enable short-lived or subtle lincRNA
functions to be studied in an isogenic background.
Initially, we tested a reported HHRz chemical inhibitor, toyoca-
mycin (Yen et al, 2004), to restore levels of linc1405. Cells treated
with 1.5 μM toyocamycin for 12 h partially recovered linc1405 levels
(to ~30% of wild-type), but this was accompanied by massive cell
death and perturbation of housekeeping genes such as TBP
(data not shown). The drastic effect on cellular viability is
consistent with toyocamycin effects when used in Toxoplasma
gondii (Agop-Nersesian et al, 2008). As an alternative strategy, we
tested if an ASO designed to bind the HHRz cleavage site could
inhibit HHRz activity. In this way, we rescued linc1405 levels to ~50%
of wild-type expression in a dose-dependent manner in 24 h (Fig 4C).
Our approach combining the HHRz knockdown and rescue experi-
ments can, therefore, be applied to study both long-lived and short-
duration effects of lincRNA expression, in an isogenic background.
In summary, the HHRz approach is a useful addition to the
expanding range of methods (e.g., ASOs, CRISPR-Cas13, and shRNAs)
for dissecting the functions of lincRNA genes, and in particular, for
testing the role of the RNA product (Bassett et al, 2014). Using the
HHRz, a reasonable knockdown is achieved for approximately half
of the tested lincRNA genes, and in these cases, there are several
Figure 4. The ribozyme approach distinguishes RNA-
dependent and RNA-independent functions of
lincRNA genes.
(A) Diversity of knockdown efﬁciencies for 15 selected
lincRNAs, targeted by genomic integration of the HHRz
and assessed using RNA-seq analysis across the
collection of 140 cell lines. The expression of the
lincRNAs targeted in the knockdown cell lines is shown,
normalised to the median of all other cell lines. Each
point corresponds to a biological replicate/cell line
and the bar is the median across replicates. G9amRNA
expression across the G9a HHRz cell lines is shown for
reference. (B) Representative knockdown of linc1509
using the HHRz. RNA-seq reads across the linc1509 pre-
lincRNA (including introns) are shown, comparing the
average read depth in non-targeted cell lines (black)
with that in cell lines with the HHRz in linc1509 exon
2 (top) or exon 3 (bottom) (red). (C) Rescue of linc1405
expression in HHRz depleted linc1405 cell lines using
an oligonucleotide that blocks ribozyme cleavage.
Linc1405 expression measured by qPCR across a wild-
type cell line (white) and a linc1405 HHRz cell line (red),
treated with increasing concentrations of the
oligonucleotide. As a negative control, the linc1405
HHRz cell line was treated with a non-complimentary
oligonucleotide (“−ve control”). Dots represent
individual measurements (two biological replicates,
each with three technical replicates), and statistical
signiﬁcance was assessed using a two-tailed t test.
(D) Expression of genes neighbouring eight lincRNA
loci, in cell lines where those lincRNA loci were
targeted by HHRz integration (coloured triangles) or
genomic deletion (coloured crosses). Gene expression
was measured by RNA-seq and normalised to median
expression in non-targeted cell lines (grey points).
Median expression differences between targeted and
non-targeted groups of cell lines were tested for
signiﬁcance using a Monte Carlo simulation, applying
the Bonferroni correction for multiple hypothesis
testing. (E) Expression of linc1405 (red) and the
neighbouring gene Eomes (black) across the
differentiation time course, measured by bulk RNA-seq
(n = 2 biological replicates). For each gene,
measurements are centred on the mean and scaled by
standard deviation. (F) Assessment of correlated
expression across mESCs and NPCs of cis-linked gene
pairs involving one lincRNA gene, quantiﬁed by
Euclidean distance using single-cell RNA-seq data. The
% of gene pairs (in 200 kb bins) with Euclidean
distances below the 1% signiﬁcance threshold
(determined in Fig S4A by examining distant gene pairs) is shown. In the absence of proximity-dependent effects, we expect only 1% of gene pairs to be correlated below
this threshold. (G) Representative single-cell RNA-seq tracks (three mESCs and three NPCs) for the genomic neighbourhood around linc_2485 (red bar). Genes co-
expressed with linc_2485 (according to Fig S4A) are indicated as black bars. See also Figs S3 and S4 and Table S4A and B.
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beneﬁts: there are no off-target effects (as the ribozyme acts in cis),
the depletion is stable over many cell divisions, and RNA levels can
be rescued using a blocking ASO. Therefore, as we now began to
examine the functions of our shortlisted lincRNA genes in more
detail, where possible, we included lincRNA HHRz knockdown cell
lines alongside lincRNA gene deletions.
Distinguishing cis and trans functions of lincRNA genes
LincRNAs are primarily suggested to regulate gene expression,
either in cis (adjacent genes) or in trans (distant genes). To examine
the functions of our shortlisted lincRNA genes (see Table 1 for main
selection criteria), we generated cell lines using CRISPR-Cas9 to
delete entire genomic lincRNA loci. A list of cell lines generated, the
size of deleted regions, and the Cas9 guides used are provided in
Table S4A and B. We analysed these cell lines together with the
HHRz cell lines by RNA-seq to identify local and/or global changes
in gene expression. The comparison between genomic deletion
and ribozyme-mediated knockdown helps to distinguish DNA-/
transcription-dependent functions from RNA-dependent functions.
In total, we sequenced 140 cell lines (HHRz and genomic deletions,
plus wild-type controls, Table S4A) to assess whether the resulting
gene expression changes are a speciﬁc consequence of lincRNA
(gene) perturbation.
We ﬁrst looked for global transcriptional changes in the lincRNA
gene deletion cell lines, using wild-type cell lines and cell lines with
neutral integrations or genome edits as controls (Fig S3A and Table
S4A). Upon Miat deletion, genes involved in cell cycle progression
(e.g., Cul1, Cks2, Taf10, and replication-dependent histone genes) or
cardiac muscle development (Sox6) were misexpressed. This is
consistent with the reported roles of Miat in myocardial infarction
and cell cycle regulation (Ishii et al, 2006; Lai et al, 2017) and with the
cell cycle stage–speciﬁc expression of Miat we observed by single-
cell RNA-seq. For the linc1400 deletion cell lines, the pluripotency
factor Klf2 was down-regulated (Fig S3A), which supports the
previously reported role of linc1400 in inﬂuencing the pluripotency
network (Guttman et al, 2011). We also observed several changes in
the linc1405 and Tuna deletions, and upon Firre deletion, the ad-
jacent gene Stk26 was down-regulated (Fig S3A). Comparing our
results with published Tuna shRNA, Firre ASO and Firre deletion
datasets (Hacisuleyman et al, 2014; Lin et al, 2014; Bergmann et al,
2015) revealed only a small degree of overlap (Fig S3A), which may
be due to differences in the experimental timescales or growth
conditions (we used serum + LIF medium, whereas the Firre de-
letion was previously studied using 2i medium), or the conservative
nature of our approach whereby we includedmany negative control
cell lines. Nonetheless, for 5/10 lincRNA loci we tested, we observed
some evidence of functions in trans.
We next looked for local effects in the neighbourhood of deleted
lincRNA loci (Fig 4D), ﬁnding that deletion of the linc1405 and Firre
genes decreased the expression of the neighbouring genes Eomes
and Stk26, respectively. Expression of linc1405 and Eomes are also
strongly correlated during mESC to NPC differentiation (Fig 4E, bulk
RNA-seq). Eomes is 70 kb away from linc1405, whereas Stk26 is
205 kb away from Firre. The direct regulation of neighbouring genes
by these lincRNA loci suggests that they function as enhancer-like
elements. Our results are consistent with an orthogonal study of
linc1405 function using promoter deletions and poly(A) site in-
sertions and a recent study which identiﬁed an intronic region of
Firre that can function as a DNA enhancer element in a reporter
assay (Engreitz et al, 2016; Hacisuleyman et al, 2016). We also ob-
served a tendency for genes adjacent to linc1543 and linc1503 to be
down-regulated in some but not all cell lines when these lincRNA loci
were deleted (Fig 4D). These clonal differences suggest that additional
local buffering mechanisms (e.g., epigenetic modiﬁcations) maintain
neighbouring gene expression and affect the ability of linc1405 to
activate Eomes. For the Miat deletion, we did not observe changes in
neighbouring gene expression, suggesting that the transcriptome-wide
changes we see (Fig S3A) arise from Miat acting in trans.
Extrapolating our results, we predict that up to a third of lincRNA loci
potentially inﬂuence local gene expression, which would be consistent
with estimates from two orthogonal studies (Goff et al, 2015; Engreitz
et al, 2016). However, this must be tested further, including in different
cell types, and ideally testing hundreds or thousands of loci.
To explore how lincRNA loci might regulate neighbouring genes
(i.e., whether the RNA is required), we compared our HHRz and
deletion cell lines (Fig 4D). We obtained the clearest data for
linc1405, for which the locus deletion reduced Eomes expression,
but the RNA knockdown with the HHRz did not. This suggests that
the linc1405 locus promotes Eomes expression by acting as a DNA
element or via the act of transcription, and the RNA product is not
required. The absence of transcriptome-wide changes in gene
expression in the ribozyme datasets (e.g., linc1611 analysis shown in
Fig S3B) conﬁrms that the ribozyme approach does not suffer from
off-target effects.
We re-examined all our RNA-seq data and found that numerous
lincRNAswere co-expressedwith adjacent genes (Figs 4F and S4A and
B) and over large linear genomic distances (e.g., in the lincRNA_2485
neighbourhood, Fig 4G). These broad co-expressed genomic regions
suggest that cis-regulation involving lincRNA genes could be wide-
spread, although this can also reﬂect co-regulation of nearby mRNA
and lincRNA pairs. To distinguish between these possibilities on
a gene-by-gene basis, further lincRNA knockdown and deletion ex-
periments will be required.
In summary, combining our bulk and scRNA-seq data with
lincRNA knockdowns and deletions highlights how lincRNA genes
can function in a variety of ways (in cis or in trans, and in an RNA-
dependent or RNA-independent manner). This underscores the
importance of testing the role of the RNA product with knockdown
approaches, such as the HHRz method we introduce, ASOs, or
CRISPR-Cas13. These methods can easily show when an RNA
product is functional (as we demonstrate for G9a mRNA, Fig 3D).
However, as no knockdown method completely removes the RNA,
for loci such as linc1405 that appear to function as DNA elements or
via the act of transcription, it is impossible to exclude a role for the
transcript without additional evidence. We therefore sought an
orthogonal approach to distinguish functional lincRNA transcripts
from those that are most likely dispensable by-products.
Global proﬁling of the nuclear RNA decay landscape
The functions of yeast lncRNAs are tightly linked to their properties
(transcriptional processivity, nuclear stability, and localisation) (Xu
et al, 2009; Castelnuovo et al, 2013), and this concept was recently
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extended to mammalian lincRNAs (Mele´ et al, 2017; Schlackow et al,
2017). Therefore, we reasoned that an in-depth analysis of lincRNA
properties would shed light on how different lincRNA genes
might function. The simplest model is that unstable lncRNAs are by-
products of (potentially functional) transcription or DNA elements,
whereas lncRNAs with longer, mRNA-like half-lives may accumulate to
high levels and function as transcripts. Unfortunately, recent studies of
human lincRNA stability reported conﬂicting results, and so it remains
unclear whether lincRNAs are generally less stable than mRNAs or not
(Mele´ et al, 2017; Schlackow et al, 2017).
To resolve this key question, we obtained our own set of
transcriptome-wide RNA half-life measurements for mESCs, by
monitoring global RNA levels following transcription shut-off by
actinomycin D. Compared with mRNAs, lincRNAs had a slightly
shorter median half-life when expression levels were considered
(Fig 5A and B). Repeating the analysis with more stringent ﬁlters for
half-life measurements or lincRNA annotations revealed a similar
trend, but this was not always statistically signiﬁcant (data not
shown). Furthermore, these analyses do not tell us where or when
an RNA is degraded in the cell. Together with the inconclusive
results from human cell lines (Mele´ et al, 2017; Schlackow et al, 2017),
this motivated us to develop amore precise way to monitor lincRNA
degradation, by directly measuring lincRNA interactions with the
decay machinery.
In yeast, lncRNA classes are distinguished by differential tar-
geting by the nuclear exosome and its cofactor complexes (e.g.,
TRAMP, Trf4/5-Air1/2-Mtr4 polyadenyaltion), and based on exo-
some knockdown studies, the same appears to be true in mammals
(Schlackow et al, 2017). We reasoned that identifying interactions
between the nuclear exosome and its substrates would, therefore,
offer the deepest insights into lincRNA degradation. To this end, we
determined the direct, transcriptome-wide targets of the nuclear
exosome–associated helicase Mtr4, using an adapted version of the
crosslinking and analysis of cDNAs method (CRAC) (Granneman et al,
2009). Brieﬂy, mESCs with homozygously FLAG-Avi–tagged (Flemr &
Buhler, 2015) endogenous Mtr4 were UV irradiated to covalently
cross-link protein–RNA complexes, and then the tagged protein was
puriﬁed. After RNase treatment and denaturing washes, the ~20- to
50-nt RNA fragments directly cross-linked to Mtr4 were sequenced.
This approach offers unique advantages over RNA half-life
measurements. First, the cells are not perturbed, and so we ac-
curately capture steady-state exosome substrates. Second, this
approach provides a direct readout of nuclear degradation, and so
the results are not complicated by the high redundancy between
RNA decay pathways. Third, we can capture transient interactions,
enabling us to monitor processes such as co-transcriptional decay.
Fourth, as Mtr4 is present in various nuclear exosome cofactor
complexes (e.g., NEXT and PAXT [Lubas et al, 2011; Meola et al, 2016]),
we simultaneously surveymany decay pathways. As we obtain high-
resolution (~20–50 nt) exosome binding sites, we can distinguish
these different decay pathways for individual genes.
We obtained four CRAC datasets for Mtr4, and one for an un-
tagged cell line. As Mtr4 targets speciﬁc regions of ribosomal RNA
precursors (Lubas et al, 2011), we validated our approach by
examining Mtr4-bound pre-rRNA fragments. As expected, this
revealed binding in the 59ETS and 39-extended 5.8S, with almost no
background (Fig S5A). Furthermore, degradation substrates in yeast
are oligoadenylated at the 39 end, providing a landing pad to recruit
Mtr4. This appears to be conserved in mammals, although to what
extent is unclear (Lubas et al, 2011; Preker et al, 2011). Therefore, we
examined our CRAC data for reads with 39 non-genome-encoded
oligonucleotide tails, ﬁnding a striking enrichment for oligo(A) tails
(present on ~10% of Mtr4-bound RNA fragments, Fig 5C). This
conﬁrms that we capture bona ﬁde degradation intermediates and
establishes oligoadenylation as a major component of mammalian
nuclear RNA decay.
We next analysed mRNAs, where Mtr4 acts in multiple decay
pathways. We were able to distinguish these decay pathways based
on RNA fragments mapping to the following mRNA regions (Fig 5D).
Exons: Mtr4 binding here reﬂects mature mRNA turnover (Lubas
et al, 2011; Meola et al, 2016).
Introns: Mtr4 binding here implicates it in intron removal. Notably,
we observed a prominent peak of oligo(A)-tailed reads mapping
to intron 39 ends (see also Fig 5E), suggesting that these act as
a landing pad for initial Mtr4 recruitment to excised introns.
Promoter-proximal regions: Mtr4 bound abundantly to RNA frag-
ments mapping to the 1-kb region downstream of the transcription
start site (TSS) (see also Fig 5F). This reﬂects the decay of unstable
“ptRNAs” arising from early transcription termination in protein-
coding genes (Ogami & Manley, 2017).
Upstream antisense regions: Mtr4 also bound abundantly to an-
tisense transcripts produced upstream of the TSS (Fig 5F). This
reﬂects the degradation of very unstable Promoter uPstream
Transcripts (PROMPTs) arising from divergent transcription initia-
tion (Preker et al, 2011).
Subsequent analyses revealed that ptRNAs and PROMPTs be-
have identically and differed only in their orientation relative to the
mRNA promoter. For clarity, we therefore refer to these transcripts
as sense PROMPTs and antisense PROMPTs (as indicated in Fig 5F).
Our Mtr4 CRAC data, therefore, report on two key stages of the
RNA Pol II transcript life cycle—early transcription termination (i.e.,
transcriptional processivity) and nuclear stability of the mature
transcript. Next, we used our data to quantitatively compare these
processes for mRNAs and lincRNAs.
LincRNAs diverge from mRNAs early in transcription
We ﬁrst compared the nuclear stability of mature lincRNAs and
mRNAs by examining Mtr4 CRAC read counts within exons (ex-
cluding PROMPT regions) and normalising to Pol II NET-seq as
a measure of transcription (performed as described by Schlackow
et al [2017]; Fig 5D and F). We used a high-quality list of lincRNA and
mRNA 59 end coordinates obtained by ﬁltering for characteristics
of active TSSs, such as speciﬁc NET-seq and H3K4me3 chromatin
immunoprecipitation sequencing (ChIP-seq) signatures (see the
Materials and Methods section and column “CRAC.biotype” in Table
S1A). We observed that on average, lincRNAs have higher Mtr4
binding across exons than mRNAs (Fig 6A and B), suggesting that
mature lincRNAs are more prevalently targeted for nuclear turn-
over, and in good agreement with their shorter half-lives (Fig 5A and
B). Our direct measurements of lincRNA targeting by the nuclear
exosome are therefore in good agreement with previous RNA-seq
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analyses of exosome-depleted cell lines (Schlackow et al, 2017).
Importantly, we also noted considerable variability between indi-
vidual lincRNAs and highlight three examples where this is con-
sistent with their predicted functions (labelled on Fig 6A). Linc1494
had high Mtr4 binding and a short half-life in our actinomycin D
experiment, and linc1494 has previously been suggested to function
as a cis-regulatory element, based on its conservation with a hu-
man enhancer (Engreitz et al, 2016). Our data suggest that the
linc1494 transcript is a nonfunctional by-product. Conversely,
Platr20 and XLOC_050881 have low Mtr4 binding and long half-lives.
Platr20 expression is associated with the pluripotent state
(Bergmann et al, 2015), and XLOC_050881 is homologous to the
human Nbdy gene, which encodes a microprotein functioning in
nonsense-mediated decay (D’Lima et al, 2016). Our data would be
consistent with XLOC_050881 and Platr20 encoding functional
RNAs.
In contrast to the relatively moderate differences in Mtr4 binding
and half-life measurements for mature transcripts, lincRNAs and
mRNAs showed large differences in Mtr4 binding at sense PROMPTs
(Fig 6B and C). For protein-coding genes, Mtr4 bound abundantly to
antisense PROMPTs but not sense PROMPTs, whereas lincRNA
genes had high levels of Mtr4 binding to both sense and antisense
PROMPTs. Because Mtr4 binding to PROMPTs reﬂects early tran-
scription termination (Ogami & Manley, 2017), we conclude that
protein-coding genes are more processively transcribed in the
forward direction than in the reverse direction. Conversely, tran-
scription from lincRNA TSSs is termination-prone in both directions
(Fig 6B and C). Notably, even abundantly expressed lincRNAs had
Figure 5. The nuclear RNA degradation landscape of
mESCs.
(A) Half-lives of mRNAs and lincRNAs, calculated from
RNA-seq decay curves following actinomycin
D–mediated transcription shut-off. Messenger RNAs
are shown in black, lincRNAs in red, and lincRNAs
highlighted in this study in green. A running median
trend line for mRNAs is shown in blue. (B) Box plot
summary of lincRNA and mRNA half-lives (bar =
median; notches = 1.58 × IQR/sqrt(n)), with the
distributions tested for similarity using the Wilcoxon
rank sum test. The three plots show low expressed (<40
normalised counts), high expressed (>40 normalised
counts), or all transcripts (left to right). (C) Length of
non-genome-encoded oligonucleotide tails detected
on RNA fragments captured by Mtr4 CRAC. Oligo(A) tails
correspond to degradation intermediates and oligo(C/
G/T) tails are shown as a negative control. (D)
Metaplots showing the distribution of Pol II Native
Elongating Transcript sequencing (NET-seq) (top) and
Mtr4 CRAC (middle) RNA fragments around the start
and end of mRNA exons and introns (ﬁrst three and
the last exon shown). Mtr4 CRAC RNA fragments with
non-genome-encoded 39 oligo(A) tails, corresponding
to initial Mtr4 recruitment sites, are shown separately
(bottom). (E) An example of Mtr4 CRAC reads mapping
near the 39 end of an intron (β-actin intron 1).
Individual sequencing reads corresponding to
fragments with 39 oligo(A) tails are shown as red bars,
with an alignment of these sequences below
(highlighting in red the non-genome-encoded oligo(A)
tails). (F) Total distribution of RNA fragments bound to
Pol II (NET-seq) or Mtr4 (CRAC) around mRNA TSSs, in
the sense (top) and antisense (bottom) directions.
“Sense PROMPTs” are deﬁned as short, prematurely
terminated transcripts originating from TSSes in the
sense direction and “antisense PROMPTs” are similar
transcripts that arise in the upstream antisense
orientation (see diagram). Mtr4 A-tailed read (as for D)
distributions are shown in green. See also Fig S5.
Dissecting mouse lincRNA gene activities Tuck et al. https://doi.org/10.26508/lsa.201800124 vol 1 | no 4 | e201800124 10 of 22
a high propensity for early termination (Fig 6C). Co-transcriptional
cleavage was previously reported across lincRNA genes (Schlackow
et al, 2017). Our results support this ﬁnding, but suggest that most
termination occurs closer to the TSS (within 50–300 nt) than pre-
viously appreciated (Fig 5F). This typical behaviour is illustrated in
Fig 6D for an mRNA and three lincRNAs.
Having identiﬁed elevated early termination as a prominent
hallmark of lincRNA transcription, we set out to identify the un-
derlying mechanism. First, we precisely deﬁned transcription ter-
mination sites, then we looked for sequence motifs at these sites.
To this end, we ﬁltered our Mtr4 CRAC data for reads with 39 oligo(A)
tails, reasoning that as these reveal initial sites of Mtr4 recruitment
to excised introns (Fig 5D and E), they would also reveal the 39 end of
premature transcription termination products in sense PROMPT
regions. Indeed, ~8% of sense PROMPT reads possessed oligo(A)
tails (Fig 5F), for which we extracted the 39 genome-encoded co-
ordinates (as demonstrated in Fig 6D for lincRNA XLOC_026132). This
provided a set of precise Pol II early termination sites in mRNA and
lincRNA genes.
Plotting the average nucleotide distribution around these ge-
nomic sites revealed an enrichment of Ts on both sides and an
enrichment of G further upstream (Fig 6E). This pattern is distinct
from that found at the 39 end of introns and conﬁrms that these are
not cryptic splice sites. In yeast, T-rich sequences coincide with the
termination site of unstable lncRNAs (Schaughency et al, 2014), and
the inherent instability of oligo(dA:rU) DNA–RNA hybrid duplexes
can facilitate transcription termination (Martin & Tinoco, 1980). We
also found a strong enrichment of Mtr4 CRAC signal immediately
Figure 6. Mature lincRNAs are degraded by the
exosome and nascent lincRNAs undergo premature
transcription termination.
(A) Comparison of Mtr4 CRAC and Pol II NET-seq read
counts for mRNA (black) and lincRNA (red) exons, with
lincRNAs studied in detail highlighted in green,
lincRNAs mentioned in the text labelled, and a trend
line for mRNAs shown in blue. For (A–C), only
transcripts for which high-conﬁdence TSSes could be
assigned are included (see the Materials and Methods
section and column “CRAC.biotype” in Table S1A).
(B) The ratio of Mtr4 CRAC to Pol II NET-seq read counts
for mRNA and lincRNA exons, introns, and sense and
antisense PROMPTs, using the most stringent set of
criteria to select lincRNA genes (genes >2 kb long and
>5 kb away from neighbouring coding genes). A
Wilcoxon rank sum test was used to compare lincRNAs
and mRNAs. The bar indicates the median values, and
notches = 1.58 × IQR/sqrt(n). (C) Mtr4 CRAC and Pol II
NET-seq read counts in mRNA (black) and lincRNA
(red) sense PROMPT regions. The CRAC RNA fragments
arising here reﬂect short, early transcription
termination products. LincRNAs studied in more detail
are highlighted (green) and a trend line for mRNAs is
shown in blue. (D) Genome browser snapshot showing
Mtr4 CRAC and Pol II NET-seq reads across
a representative mRNA (Cxxc1; top) and three lincRNAs
(XLOC_026132, XLOC_047481, and XLOC_008616).
Regions for which reads were counted in are (A–C)
indicated, as are oligo(A)-tailed reads that we detect
for XLOC_026132, corresponding to early transcription
termination sites. (E) Genomic nucleotide distributions
around PROMPT 39 ends (= premature transcription
termination sites) and intron 39 ends, deﬁned by
analysing Mtr4-bound oligo(A)-tailed fragments that
map to lincRNA and mRNA genes. Within introns, two
classes of 39 ends can be distinguished, with
nucleotide signatures corresponding to 39 splice sites
(bottom right) or, when intron 39 ends are ﬁltered out,
early termination sites (top right). See also Fig S6.
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upstream of the 59 boundary of promoter-proximal nucleosomes in
mRNA and lincRNA genes (Fig S6A). This ﬁnding is consistent with
a recent report that nucleosome remodelling factors can suppress
noncoding transcription in mESCs (Hainer et al, 2015). Together, our
data point to underlying DNA sequence and nucleosomes as strong
driving forces for Pol II early termination, which is prevalent for
lincRNA genes.
In summary, we found that lincRNAs are distinguished from
mRNAs at multiple steps, including early termination of nascent
transcripts as well as exosome-mediated decay of mature lincRNAs,
helping to explain the low lincRNA expression levels even in single
cells. In contrast to mRNA genes, lincRNA genes generate more
short, promoter-proximal RNAs and fewer full-length transcripts.
Together with the local enhancer-like functions of lincRNA loci that
we experimentally observed, one possibility is that some of these
lincRNA genes act as DNA elements or through transcription, with
the RNA a dispensable by-product. This is apparently the case for
linc1405 and several other lincRNA loci (Engreitz et al, 2016).
However, lincRNAs might also act as transcripts, despite being low
in abundance (Seiler et al, 2017). Therefore, the role of the transcript
must always be tested experimentally, taking advantage of the
rapidly developing range of lincRNA-directed methods.
Discussion
More than a decade after their discovery, many questions remain
unanswered about lincRNA genes, such as (i) which are functionally
relevant, and for those that are, (ii) is the RNA itself functional? The
greatest challenges in answering these questions are the over-
whelming number of lincRNA genes, which must somehow be
prioritised for in depth analysis, and the current lack of methods
to distinguish RNA-dependent from RNA-independent functions
(Bassett et al, 2014). By comprehensively identifying lincRNAs
expressed in speciﬁc cell types (ESC or NPC), across subpopulations,
and during speciﬁc cell cycle stages and examining which mRNAs
are co-expressed with these lincRNAs, our study provides a sys-
tematic and detailed list of candidates for in-depth functional studies.
Deleting a selection of these lincRNA loci revealed transcriptome-
wide and local regulation of gene expression, suggesting that both
modes of lincRNA gene activity are common.
Furthermore, we introduce a ribozyme-based approach that
depletes lincRNAs with minimal perturbation of the genomic locus.
This can reveal when an RNA product is functional, which we
demonstrate using the G9a mRNA as proof of principle. The ribo-
zyme approach was effective for approximately half of the tested
lincRNAs, and although we were unable to knockdown two lincRNAs
for which we saw evidence of trans functions (Miat and Tuna, Fig
S3A), orthogonal studies of these lincRNAs support an RNA-
mediated role (Lin et al, 2014; Lai et al, 2017). Some of the
lincRNA genes we studied in mESCs may have played greater roles
in other cell types, as is the case for Meteor (linc1405), which was
recently shown to play a role during mesendoderm differentiation
(Alexanian et al, 2017). Although the ribozyme approach requires
some effort to implement and does not always achieve a strong
knockdown, a major advantage is that the lincRNA depletion is
stable and reversible, so the effects of lincRNA depletion at various
stages during mESC differentiation to alternative cell types can be
studied. Considered together, ribozyme, ASO, and CRISPR-Cas13
technologies present a powerful range of knockdown approaches
that should be widely adopted to test which lincRNA genes function
through their RNA product. These approaches would also be
suitable for investigating antisense lincRNA–mRNA pairs (the ribozyme
is strand speciﬁc), which are likely to constitute important regulatory
circuits.
Using the ribozyme method, we were able to deplete transcripts
by 50–90% from lincRNA loci that appear to act in cis as enhancer-
like elements (linc1405, linc1503, and linc1543). These knockdowns
did not affect neighbouring gene expression, in contrast to the
lincRNA locus deletions, and we speculate that these lincRNA loci
act independently of the RNA product. As some RNA remains, we
cannot rule out the possibility that the remaining RNA was sufﬁ-
cient for function (a caveat of any knockdown method). Parallel
approaches can help resolve this ambiguity, such as looking at the
properties of the RNA. For example, in the case of the linc1405 locus,
which enhances expression of the neighbouring gene Eomes, our
CRAC analysis revealed the transcript to be highly unstable and
therefore most likely a dispensable by-product. Furthermore,
a previous study (Engreitz et al, 2016) reported a direct contact
between the linc1405 and Eomes loci and found that blocking
linc1405 transcription with a poly(A) signal does not prevent
linc1405 activating Eomes expression. Therefore, the DNA ele-
ment or promoter-proximal transcriptional activity of the
linc1405 locus appears to be sufﬁcient for contacting and acti-
vating expression of Eomes. We suggest that a strategy combining
locus deletion, poly(A) integration, HHRz/ASO/CRISPR-Cas13
knockdown, and inspection of RNA properties is the most in-
formative approach for investigating new lincRNA genes. Notably,
the Pvt1 locus was also shown to function via its promoter element,
which competes for contacts with enhancers (Cho et al, 2018). LincRNA
genes that function via modulating chromatin contacts may be a re-
curring theme.
Genes encoding lincRNAs that function without requiring the
RNA product may be common, and recently there has been growing
support for thismodel (Ard et al, 2017). Our comprehensive analyses
of lincRNA expression, stability, and transcription provide further
evidence for this. Not only are lincRNAs targeted by the exosome for
post-transcriptional degradation in the nucleus, in agreement with
a recent study (Schlackow et al, 2017), but also more strikingly, we
ﬁnd that lincRNA genes undergo extensive early transcription
termination within 1 kb of the TSS. This suggests that lincRNAs are
distinguished from mRNAs even earlier in transcription than pre-
viously appreciated (Fischl et al, 2017; Schlackow et al, 2017) and
that this early stage of transcription is critical for determining
RNA fate. Furthermore, this explains why RNA Pol II CTD threonine
4 phosphorylation, a hallmark of transcription termination, is de-
tected immediately downstream of lincRNA promoters (Schlackow
et al, 2017).
There is lower Pol II accumulation in promoter-proximal regions
of lincRNA genes than mRNA genes, which was previously inter-
preted as reduced Pol II pausing in lincRNA genes (Schlackow et al,
2017). Instead, our data suggest that the lower Pol II detection at
promoter-proximal regions of lincRNAs is indicative of higher
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termination and increased Pol II dissociation from the template. By
examining the precise 39 ends of early-terminating lincRNAs and
mRNAs, we ﬁnd a preference for T-rich genomic regions at either
side of the termination site and a strong correlation with nucle-
osome positioning. This suggests that the intrinsic instability of the
RNA–DNA duplex in this region, combined with the blocking effect
of the nucleosome, promotes Pol II early termination (potentially
without requiring canonical cleavage and polyadenylation signals).
We speculate that during the early stages of transcription, the Pol II
complex is more prone to termination by such mechanisms,
whereas the more stable Pol II elongation complex further
downstream is resistant. Overall, our data support amodel whereby
Pol II transcribing mammalian lincRNA genes rarely transitions into
productive elongation, as observed in yeast (Milligan et al, 2016;
Fischl et al, 2017).
The fact that lincRNAs are low in abundance and prone to
premature transcription termination and degradation suggests that
in some cases, the lincRNA gene might not require the RNA product
for function. However, some lincRNAs (e.g., VELUCT) function despite
having a low abundance (Seiler et al, 2017), and low lincRNA levels
could be ideal for some RNA-dependent functions. For example,
local gene regulation might only require a small number of lincRNA
molecules, forming a high local concentration, in which case, the
high RNA turnover rate would prevent lincRNAs diffusing away and
perturbing other regions. Furthermore, our analyses reveal that
some lincRNAs are more stable and/or abundant, which would
make them well suited to functioning in trans, as appears to be the
case for Miat, Rmst, and a growing number of lincRNAs. Rmst is
particularly interesting, as we ﬁnd it is expressed preferentially in
the G2/M phase in NPCs (Fig 2G), and it was previously reported to
recruit Sox2 to the promoters of neurogenic transcription factor
genes (Ng et al, 2013). As neural progenitors have amuch longer G2/M
phase than ESCs, speciﬁc expression in G2/M may help restrict Rmst
expression to differentiating cells.
In summary, it is now clear that when studying a lincRNA gene, it
is critical to consider the roles of transcription, the DNA element,
and the RNA product (Bassett et al, 2014). This will be greatly aided
by the continued development of lincRNA-directed techniques and





For the mESC to NPC differentiation, we used male mESCs from
C57BL/6J female × Mus musculus castaneus male (BC8) and Mus
musculus castaneus female × C57BL/6J male (CB9) crosses (Sun
et al, 2012). For all other experiments, we used male mESCs from
a 129 × C57BL/6 cross (Mohn et al, 2008). For tagging endogenous
Mtr4, the 129 × C57BL/6 mESCs were modiﬁed by the genomic in-
tegration of the birA biotin ligase and the CreERT2 recombinase
fusion in the Rosa26 locus (Flemr & Buhler, 2015). A list of all cell
lines used in this study is provided in Table S4.
Cell culture
mESCs were mostly cultured in serum + LIF medium (DMEM, 0.1 mM
nonessential amino acids, 1 mM sodium pyruvate, 2 mM L-gluta-
mine, 15% (vol/vol) FBS, 0.1 mM β-mercaptoethanol, 50 μg/ml
penicillin, 80 μg/ml streptomycin, and home-made LIF condi-
tioned medium) on gelatin-coated dishes. Where indicated, mESCs
were grown in 2i medium (NDiff 227; StemCells, with 0.33 vol/vol LIF-
conditioned medium, 1 μM MEK inhibitor PD 0325901 [Tocris], and
3 μM GSK3 inhibitor CHIR99021 [Calbiochem]) on gelatin-coated
dishes. All cell cultures were grown at 37°C with 5% CO2.
ES to NPC differentiation
mESCs were cultured for two passages on gelatin-coated plates
before dissociating with trypsin, washing twice in PBS, and seeding
(4 × 106) on bacteriological Greiner Petri dishes in 15-ml cell ag-
gregate (CA) medium (DMEM with 0.1 mM nonessential amino acids,
2 mM L-glutamine, 10% [vol/vol] FBS, and 0.1 mM β-mercaptoethanol).
The plates were gently shaken twice per day to avoid very large CAs
forming. CA medium was replaced after 2 d, by gently transferring the
CAs into a 50-ml Falcon tube using a 25-ml pipette, allowing the CAs to
settle for 5 min, resuspending the CAs in fresh CA media using a 25 ml
pipette, and transferring the CAs into a fresh dish. CA medium was
replaced again after a further two days and retinoic acid added (5 μM
ﬁnal concentration). The medium was again replaced after a further
two days, with CA medium + 5 μM retinoic acid.
For bulk RNA-seq, CAs were washed once in PBS, the supernatant
removed, and cells frozen at −80°C. For single-cell RNA-seq, CAs
were washed in PBS, dissociated in Accutase, and then passed
through a cell strainer to remove cell clumps/debris.
Stable cell line generation
Cell lines containing stable hammerhead ribozyme or guanine-
responsive Hepatitis Delta virus aptazyme integrations were gen-
erated by transfecting SpCas9-sgRNA-2A-mCherry, encoding guides
designed to cut close to the integration site (Knuckles et al, 2017),
and either an ssODN with 45-nt homology arms (hammerhead
ribozyme) or a pBluescript II KS(−) plasmidwith the insert and ~500-bp
homology arms cloned between KpnI and SacI restriction sites (HDV
aptazyme). A corresponding GFP homologous recombination re-
porter was also co-transfected (Flemr & Buhler, 2015), and after 24 h,
GFP + mCherry double positive cells were sorted by FACS and 10,000
seeded on a 10-cm dish. For deletion cell lines, an identical protocol
was used, except two SpCas9-sgRNA-2A-mCherry and two pRRE200
reporter plasmids were simultaneously transfected, with the sgRNAs
targeting sites 3- to 80-kb apart to delete the enclosed region.
For CRAC, a cell line with Mtr4 tagged with a 3× FLAG-AviTag was
generated by transfecting plasmids encoding a Transcription
Activator-Like Effector Nuclease pair targeting the Mtr4 N terminus
and an ssODN with 45-nt homology arms, together with a puro-
mycin homologous recombination reporter (Flemr & Buhler, 2015).
Cells were selected for 36 h with puromycin (2 μg/ml).
For all cell lines, clones were grown for ~5–7 d and then screened
by genomic DNA extraction and PCR using the QIAGEN Fast Cycling
PCR kit. Homozygous positives were veriﬁed by Sanger sequencing
across the target locus.
All transfections were performed using 3 μl Lipofectamine 3000
reagent per μg DNA in OptiMEM.
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Reagents used in this study.
Source Product ID
Cell lines
C57BL/6J × CAST mESCs From: Sun et al (2012) N/A
CAST × C57BL/6J mESCs From: Sun et al (2012) N/A
129 × C57BL/6 mESCs From: Mohn et al (2008) N/A
Chemicals, peptides, and recombinant proteins
DMEM Gibco 21969-035
Nonessential amino acids Gibco 11140035
100 mM Sodium pyruvate Gibco 11360070





Dulbecco’s PBS Gibco 14190
Trypsin (TPCK-treated) Sigma-Aldrich T8802
Retinoic acid Sigma-Aldrich R-2625
GSK3 inhibitor CHIR99021 Calbiochem 361559
MEK inhibitor PD 0325901 Tocris 4192
NDiff227 medium Stem Cells SCS-SF-NB-02
OptiMEM Gibco 31985070
Lipofectamine 3000 Transfection kit Invitrogen L3000015
cOmplete Protease Inhibitor Cocktail Roche 11836145001
Proteinase K Roche 3115879001
SuperScript III Life Technologies 18080085
Anti-FLAG M2 magnetic beads Sigma-Aldrich M8823
3× FLAG peptide Sigma-Aldrich F4799-25MG
Dynabead M-280 Streptavidin Invitrogen 11206D
RNace-It Ribonuclease Cocktail Agilent 400720
TSAP Thermosensitive Alkaline Phosphatase Promega M9910
RNasin Ribonuclease Inhibitor Promega N2115
Recombinant RNasin Ribonuclease Inhibitor Promega N2511
miR-cat 33 conversion oligo pack IDT Custom order
T4 RNA Ligase 1 (ssRNA Ligase) NEB M0204L
T4 PNK, T4 polynucleotide kinase NEB M0201L
Hybond-C Extra membrane GE Healthcare RPN303E
Kodak BioMax MS autoradiography ﬁlm Kodak 8222648
MetaPhor agarose Lonza 50180
NuPAGE 4–12% (wt/vol) polyacrylamide Bis-Tris gels Life Technologies NP0335
NuPAGE LDS sample buffer 4× Life Technologies NP0007
NuPAGE SDS-MOPS running buffer Life Technologies NP0001
NuPage transfer buffer Life Technologies NP00061
MinElute Gel Extraction kit Qiagen 28604
Proteinase K Roche 03115836001
(Continued on following page)
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Ribozyme reporter assays
To test theHDV ribozymeandaptazymes, thepsiCHECK-2 vectorwasused,
with the various sequences cloned downstream of the renilla gene. The
plasmids (100 ng) were transfected into mESCs using the Lipofectamine
3000 Transfection kit, and after 24 h of incubation, the medium was
replaced with fresh medium containing either guanine (100 μM with
400 μM NaOH) or 400 μM NaOH (control treatment). Luciferase assays
were performed 48 h post-transfection using the Dual-Luciferase Re-
porter Assay System according to the manufacturer’s protocol. Lucif-
erase activities were measured with a microplate luminometer (Centro
LB 960; Berthold Technologies). Renilla was normalised to ﬁreﬂy and all
values represent the mean ± SD from three biological replicates.
To test the hammerhead ribozyme, the wild-type or mutant
ribozyme sequences were inserted into the 39-RNA end accumulation
during turnover (TREAT) reporter (Horvathova et al, 2017) downstream
of the GFP ORF. U2OS cells were transfected with the HHRz-active or
HHRz-inactive reporter in six-well dishes. Selection was performed
using G418 at 500 μg/ml in McCoy’s 5A supplemented with 10% FBS.
After oneweek, cells were expanded and then sorted by FACS for RFP+
and GFP+ cells. The cells were further expanded and sorted a second
time. Fluorescence intensities were measured using the Yokogawa
CV7000 high-throughput Cytological Discovery System. The following
active and inactive HHRz sequences were used, including ﬂanking
regions predicted using the AntaRNAweb server (Kleinkauf et al, 2015)
and checked for minimal ribozyme-ﬂank interactions using RNAs-









Ribozyme inhibition with an ASO
Transfections of 15 pmol fully modiﬁed 29-O-methoxy ethyl/
phosphorothioate oligonucleotides were performed using 1.5 μl
Lipofectamine 3000 reagent and 100 μl OptiMEM, which was added
to 250,000 mESCs in 250 μl mESC medium. For lower concentrations,
less of the oligo/Lipofectamine/OptiMem mix was added (20 μl or
4 μl). The medium was replaced after 6-8 h with fresh mESC me-
dium, and RNA extracted after a total of 24 h using the Norgen Single
Cell RNA puriﬁcation kit. The oligos GAAAACACATCCGGTGACAG (HHRz#2)
and CGTTCTCGAGCCGACTCACA (negative control) were used. The an-
tisense oligonucleotides were fully modiﬁed with 29-O-(2-methox-
yethyl) chemistry (29-MOE) and C nucleotides were further modiﬁed
with a methyl at the 5 position (5-methyl-29MOE-C).
qRT–PCR
For qRT–PCR of mESC ribozyme cell lines, RNA was extracted using
the Agilent Absolutely RNA Miniprep kit and 500 ng used for reverse
transcription with the Primescript RT Kit. qRT–PCR was performed
using the SsoAdvanced SYBR Green Supermix on a CFX96 Real-Time
PCR System. Relative RNA abundance was calculated from CT values
using the ΔCT method and normalising to TBP mRNA levels.
Sequencing library construction
For single-cell RNA sequencing, 4,000 cells were loaded onto a 10-
to 17-μm Fluidigm C1 Single Cell mRNA Seq IFC, and the cells were
captured according to the manufacturer’s instructions. The cap-
tured cells were manually annotated under a microscope, to
identify capture chambers containing cell debris, dead cells, no
cells, or multiple cells. Reverse transcription and cDNA pre-
ampliﬁcation was then performed in the 10- to 17-μm Fluidigm C1
Single Cell mRNA Seq IFC using the SMARTer Ultra Low RNA kit for
the Fluidigm C1 System and Advantage 2 PCR kit. cDNA was har-
vested and diluted to 0.1–0.3 ng/μl. Sequencing libraries were then
prepared using the Nextera XT DNA Sample Preparation kit and
Nextera XT DNA Sample Preparation Index kit according to the
Fluidigm instructions, “Using the C1 Single-Cell Auto Prep System to
GeneratemRNA from Single Cells and Libraries for Sequencing.” The
96 libraries from one IFC were pooled and 150-bp paired-end se-
quencing performed on the Illumina HiSeq2000.
For bulk RNA sequencing of mESCs and NPCs from the differ-
entiation time course, RNA was extracted and libraries prepared
using the Wellcome Trust Sanger Institute sample preparation
Continued
RNase H NEB M0297L
TaKaRa long and accurate (LA) Taq Clontech RR002M
γ32P-ATP 0.5 mCi 18.5 MBq Spec act. >6,000 Ci/mmol Hartman SRP-501
RCC RNA Spike-In Mix 1 Ambion 4456740
Single Cell RNA Puriﬁcation kit Norgen 51800
Recombinant DNA
SpCas9-sgRNA-2A-mCherry Knuckles et al (2017)
pRRE200 homologous recombination reporter Flemr & Buhler (2015)
pRRP200 homologous recombination reporter Flemr & Buhler (2015)
pBluescript II KS(–) Stratagene
psiCHECK-2 Promega C8021
Oligonucleotides are listed in Table S5 IDT
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pipeline with Illumina’s TruSeq stranded RNA Sample Preparation
Kit including ribosomal depletion step (RiboMinus). RNA and library
quality control was performed by the WTSI sequencing facility. For
bulk RNA sequencing of mESC ribozyme cell lines, RNA was
extracted using the Agilent Absolutely RNA Miniprep kit, ribosomal
RNA depleted using the ribo-zero rRNA removal kit, and libraries
prepared using the ScriptSeq V2 RNA-Seq Library Preparation kit.
CRAC
mESCs were grown in 2 × 15-cm dishes to ~80% conﬂuency, the
dishes washed twice with PBS, the PBS removed, and cells cross-
linked on ice (with the dishes facing up) in a Stratagene Stratalinker
2400 (400 mJ⋅cm−2). The cells were lysed by incubating with 10 ml
RIPA buffer in the dish on ice for 30 min (50 mM Tris–HCl, pH 7.8,
300 mM NaCl, 1.0% Nonidet P40 substitute, 0.1% SDS, 10% [vol/vol]
glycerol, 0.5% sodium deoxycholate, 1 mM β-mercaptoethanol, and
1× cOmplete Protease Inhibitor Cocktail). The cells were further
disrupted using a cell scraper and then lysates collected and
centrifuged at 6,500 g for 20 min at 4°C. The supernatant was snap-
frozen in liquid nitrogen until required. Note that milder extraction
conditions (e.g., 50 mM Tris–HCl, pH 7.8, 150 mM NaCl, 0.5% Nonidet
P40 substitute, and 1× cOmplete Protease Inhibitor Cocktail) can be
used for cytoplasmic or non-chromatin-associated proteins, which
will greatly improve subsequent binding to the FLAG beads.
Lysates were thawed on ice, and incubated with 100 µl anti-FLAG
M2 magnetic beads overnight. The supernatant was then removed,
and beads washed three times with 1 ml TN150 (50 mM Tris–HCl, pH
7.8, 150 mM NaCl, and 0.1% Nonidet P40 substitute). Protein–RNA
complexes were eluted by incubating the beads in 1.5 ml TN150
supplemented with 5 mM β-mercaptoethanol and 0.3 mg/ml 3×
FLAG peptide, rotating at 4°C for 2 h. The eluate was then in-
cubated with 50 µl Dynabeads M-280 Streptavidin, rotating at 4°C
overnight. The beads were washed twice in TN600 (50 mM Tris–HCl,
pH 7.8, 600 mM NaCl, 0.1% Nonidet P40 substitute, and 5 mM
β-mercaptoethanol) and twice in TN150 supplemented with 5 mM
β-mercaptoethanol. RNA was then fragmented by incubating the
beads in 500 μl TN150 supplemented with 5 mM β-mercaptoethanol
and 1 μl of 0.1 U diluted RNace-IT. After 4min at 37°C, the reactionwas
quenched by replacing the solution with 400 μl WBI (wash buffer I:
50 mM Tris–HCl, pH 7.8, 300 mM NaCl, 0.1% Nonidet P40 substitute,
5 mM β-mercaptoethanol, and 4.0 M guanidine hydrochloride). The
beads were washed twice more in WBI, then three times in 400 μl 1×
PNK (50 mM Tris–HCl, pH 7.8, 10 mM MgCl2, 0.5% Nonidet P40 sub-
stitute, and 5 mM β-mercaptoethanol).
The following four enzymatic reactions were then performed in
80 μl 1× PNK buffer (omitting the Nonidet P40 substitute), to ligate 39
and 59 adapters onto the RNA fragments. After each enzymatic
reaction, the beads were washed once in WBI and thrice in 1× PNK.
(i) Alkaline phosphatase treatment (30 min, 37°C): 8 U TSAP and
80 U RNasIN.
(ii) 39 linker ligation (overnight, 16°C): 0.1 nmol miRCat-33 DNA
linker, 40 U T4 RNA Ligase 1, 80 U RNasIN, and 12.5% (vol/vol)
PEG8000.
(iii) 59phosphorylation (1 h, 37°C): 40UT4PNKand2μl γ32P-ATP (after
30 min, add 1 μl 100 mM rATP and an additional 20 U T4 PNK).
(iv) 59 linker ligation (overnight, 16°C): 0.2 nmol 59 linker, 40 U T4
RNA Ligase 1, 1.25 mM rATP, 80 U RNasIN, and 12.5% (vol/vol)
PEG8000.
After the ﬁnal reaction, the beads were washed three times in
WBII (50 mM Tris–HCl, pH 7.8, 50 mM NaCl, 0.1% Nonidet P40 sub-
stitute, and 5 mM β-mercaptoethanol), resuspended in 30 µl 1×
NuPAGE LDS sample buffer, heated at 95°C for 2 min, and the eluate
quickly removed and loaded onto a NuPAGE 4–12% polyacrylamide
gel. The gel was run at 100 V for ~1 h, and then protein–RNA com-
plexes transferred to Hybond-C extra nitrocellulose membrane
(Amersham) at 150 V for 1.5 h using a wet transfer system andNuPAGE
transfer buffer with 15% methanol. The membrane was then brieﬂy
dried, exposed to BioMax MS ﬁlm (4 h to overnight), and the region
corresponding to the protein–RNA complex cut out.
The membrane slice was then incubated in 400 μl WBII with 1%
(wt/vol) SDS, 5 mM EDTA, and 100 μg Proteinase K at 55°C for 2 h.
The solution was then removed to another tube, 50 µl 3M NaAc, pH
5.2, and 500 µl of 1:1 phenol:chloroform mix added, and the
mixture vortexed and centrifuged at 14,000 g for 20 min. The top
phase was transferred into a new tube and 1 ml ethanol and 20 μg
glycogen added. The solution was stored at −20°C overnight to
precipitate RNA and then centrifuged at 14,000 g for 30 min. The
RNA pellet was washed once with 70% ethanol and allowed to
brieﬂy air-dry, before resuspending in 11 μl water + 1 μl 10 μM
miRCat-33 RT oligo + 1 μl 10 mM dNTPmix. The solution was heated
to 80°C for 3 min, snap-cooled on ice for 5 min, then the following
mix added: 4 μl 5× ﬁrst-strand buffer (SSIII kit) + 1 μl 100 mM DTT
(SSIII kit) + 1 μl recombinant RNasIN. After incubating for 3 min at
50°C, 200 U of SuperScript III was added and the reverse tran-
scription allowed to proceed for 1 h at 50°C. The reaction was
stopped by heating to 65°C for 15 min, then RNA digested with 10 U
RNase H at 37°C for 30 min. PCR reactions (80 μl) were then
prepared, each with 2 μl cDNA, 10 pmol P5, 10 pmol PE, 12.5 nmol
each dNTP, and 2.5 U LA Taq. Typically, we ran ﬁve PCR reactions
and then concentrated the products by ethanol precipitation
before resolving on a 3% metaphor agarose gel in 0.5× TBE. A
smear corresponding to the size of the two adapters plus inserts
(total size ~120–300 bp) was then cut out and DNA extracted using
the MinElute Gel Extraction kit, eluting in 20 μl water. If the exper-
iment was successful, we repeated the PCRs with the remaining half
of the cDNA.
Half-life measurements
To measure transcriptome-wide RNA half-lives, 300,000 mESCs
were seeded per well of 2 six-well dishes and grown for 48 h in
serum + LIF medium. The medium was replaced by fresh medium
containing 5 μM actinomycin D (from a 5 mg/ml stock in DMSO) and
the cells incubated for 30, 90, or 240 min. A mock treatment
(240 min) was included, using medium with the same amount of
DMSO but no actinomycin D. After the indicated times, the wells
were washed twice with 37°C PBS and RNA extracted using the
Agilent Absolutely RNAMiniprep kit. ERCC RNA spike-ins were added
to the lysis buffer (1.7 μl of a 1:10 dilution per sample) before it was
added to the cells. Ribosomal RNA was then depleted with the ribo-
zero rRNA removal kit and high-throughput sequencing libraries
prepared using the ScriptSeq V2 RNA-Seq Library Preparation kit.
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Quantiﬁcation and statistical analysis
LincRNA annotations
To compile a reference set of lincRNA annotations, features from
the following sources were combined:
(i) Necsulea et al (2014) lincRNA transcripts;
(ii) Guttman et al (2010) ES and NPC lincRNA transcripts; and
(iii) Ensembl GRCm38.75 lincRNAs, miscRNAs, processed_tran-
scripts, and antisense features.
Transcripts were excluded if they overlapped in either orien-
tation with protein-coding Ensembl transcripts or a variety of
“classical” noncoding RNAs deﬁned by Ensembl (including snoR-
NAs, miRNAs, rRNA, nonsense-mediated decay transcripts, and
pseudogenes). In cases where the remaining lincRNA transcripts
overlapped, they were grouped into single clusters (“genes”). A
small number of the resulting clusters were very long (>100 kb),
corresponding to regions where individual genes could not easily
be distinguished, and were excluded from subsequent analyses.
The lincRNA annotations were then combined with all Ensembl
non-lincRNA annotations to make a single reference ﬁle.
For some analyses, this reference ﬁle was also supplemented
with our own set of lincRNAs assembled from bulk RNA-seq data
using Cufﬂinks. First, reads from 10 samples (2× mESCs in serum +
LIF, 2× mESCs in 2i medium, 2× NPCs day 3, 2× NPCs day 6, and 2×
NPCs day 8) were mapped to the mm10 genome with Tophat2,
including splice sites from the reference ﬁle deﬁned in “LincRNA
annotations.” The 10 alignment ﬁles were then provided to Cufﬂinks
along with the Ensembl/Necsulea/Guttman reference ﬁle for de
novo transcript assembly, resulting in a merged set of transcript
annotations. Any novel transcripts that did not overlap with Ensembl
genes, or overlapped with a lincRNA gene, were provisionally classed
as lincRNAs. This ﬁle contains many de novo–deﬁned unannotated
transcripts and was used whenever we wanted to quantify expression
of the most complete set of noncoding RNAs. However, for analyses
where we wanted to focus on a higher quality set of lincRNAs, we
applied the following additional ﬁlters:
(i) exonic sequence >1 kb,
(ii) <50% of the exonic sequence overlaps with RepeatMasker
features,
(iii) putative lincRNAs are >5 kb away from mRNAs or “classical”
noncoding RNAs, and
(iv) expressed at ≥5 DESeq2 normalised counts per kb in at least
one mESC or NPC bulk RNA-seq sample.
LincRNAs and mRNAs that pass these ﬁlters are indicated in the
“high.quality.biotype” column of Table S1.
To deﬁne a set of 15 representative lincRNA genes for functional
studies, we additionally considered the following ﬁlters, as well as
extensive visual inspection of our RNA-seq datasets for ~200
possible candidates:
(i) low translational efﬁciency deﬁned using riboSeqR analysis of
mouse ribosome proﬁling data (Array Express study E-MTAB-
2934),
(ii) noncoding prediction by lncRScan-SVM (Sun et al, 2015), and
(iii) expressed at >30 DESeq2 normalised counts per kb in at least
one mESC or NPC sample.
Genomic regions with 20 or more genes per 100 kb were also
excluded as these were often incompletely assembled genes in
regions of lower sequencing coverage.
To quantify lincRNA versus mRNA stability and transcription
termination (half-life measurements and CRAC/NET-seq analyses),
we ﬁltered the “high.quality.biotype” lincRNAs/mRNAs further to
obtain transcripts for which there was good supporting evidence
that the annotated 59 end was accurate (e.g., speciﬁc Pol II and
H3K4me3 signatures)—see “CalculatingMtr4:PolII ratios for PROMPTs,
exons and introns.” For these analyses, we did not always require the
lincRNA to be 5 kb away from a protein-coding gene, so long as its TSS
was the “stronger” one (based on NET-seq signal).
Bulk RNA-seq analysis (ES to NPC time course)
Reads for the 10 samples were mapped to the mouse genome
(mm10) with Tophat2 and counted for features in the combined
reference ﬁle (including de novo lincRNAs) using ht-seq count
(mode = union). Feature counts were normalised using the rlog
function in DESeq2 and the 1,000 genes with the highest variance
plotted as a heat map, clustered based on pairwise Euclidean
distances between genes.
Single-cell RNA-seq analysis (ES to NPC time course)
Paired-end reads were preprocessed using Trimmomatic, with the
following settings: ILLUMINACLIP:Nextera_PE_adapters.fa:2:30:10:1:
true LEADING:28 TRAILING:28 SLIDINGWINDOW:1:28 MINLEN:50. The
reads were then aligned to mm10 using gsnap version 2015-09-29
with the following settings: –suboptimal-levels = 5 -n 1 -Q –nofails,
and providing splice sites from the combined reference ﬁle (ex-
cluding de novo lincRNAs). Reads were counted for features using
htseq-count (mode = union), and using the Ensembl/Necsulea/
Guttman reference ﬁle (but not including cufﬂinks-deﬁned novel
noncoding RNAs). In total, 672 datasets were analysed, corre-
sponding to 2 × 96 mESCs in 2i, 2 × 96 mESCs in serum + LIF, 96 NPCs
(day 6), and 2 × 96 NPCs (day 8).
A number of features were then used to ﬁlter out low-quality
cells.
(i) Visual inspection of the IFCs under the microscope (doublets,
empty wells, small cells, triplets, burst, dead, debris, and
multiple cells).
(ii) Low-quality cells deﬁned by the cellity package.
(iii) Cells with <0.5 million mapped reads.
(iv) Cells with >10% of reads from mitochondrial genes.
For principle component analysis (PCA), only mRNAs and
lincRNAs were retained. The cells were normalised using the
estimateSizeFactorsForMatrix function from DESeq2, and then PCA
performed using the prcomp function in R. The 300 genes making
the greatest contribution to each of the ﬁrst seven principle
components were then recorded as the “most variable genes,” and
these were used for subsequent clustering analyses based on
pairwise Euclidean distances. These distances were also used for
examining correlated expression of genes in cis. To compare
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single-cell and bulk RNA-seq data in the same PCA, single cell
versus bulk batch effects were ﬁrst removed using the ComBat
package in R.
To measure gene expression heterogeneity between mESCs or
between NPCs, we calculated the distance to the median, based on
the method described in (Kolodziejczyk et al, 2015). For this, we ﬁrst
calculated the squared coefﬁcient of variation of normalised read
counts for each gene, then determined the distance between this
measure and a running median (from a scatter plot of squared
coefﬁcient of variation values versus mean expression for all genes
of a similar length). In parallel for single-cell analysis alone, we
preprocessed the data using “Scater” package and performed
zero-adjusted normalisation (Lun et al, 2016; McCarthy et al, 2017).
We classiﬁed highly variable genes with FDR ≤ 0.05 and identiﬁed
~3,600 genes, including 113 lincRNAs. Highly correlated lincRNA
transcripts and mRNA genes were selected based on correlation
coefﬁcient and FDR ≤ 0.05. Representative lincRNA and mRNA
genes are shown across a tSNE projection (perplexity = 25) using
Rtsne. Cell cycle stages were assigned using a panel of G2Mmarker
genes (Kolodziejczyk et al, 2015).
CRAC and NET-seq sequencing read preprocessing and ﬁltering
Sequencing reads were preprocessed for standard analyses as
follows.
(i) The 39 adapter was removed (if present) using fastx_clipper.
(ii) Low-quality sequence was removed using the FASTX-Toolkit,
speciﬁcally fastq_quality_trimmer -t 25, fastq_quality_ﬁlter -q
20 -p 90, and fastx_artifacts_ﬁlter.
(iii) Reads with identical sequence and 59 inline unique molecule
identiﬁer, UMI, were collapsed, as they are likely to arise from
duplication during PCR.
(iv) For CRAC, low-complexity regions were trimmed from the 39
end of reads (regions of 2 nt or more where 80% ormore of the
sequence comprises the same nucleotide, for example, …
AGAAATAAAAA). This is because many Mtr4-bound RNA
fragments contain non-genome-encoded oligo(A) tails
that can lead to apparently unique mapping of repeat
RNAs.
(v) Homopolymers and dinucleotide-rich sequences were re-
moved using prinseq-lite, with the following settings -min_len
18 -lc_threshold 20 -lc_method dust.
To obtain a set of reads that do not map to repetitive regions of
the genome or small noncoding RNAs (e.g., retrotransposons,
tRNAs, snoRNAs, and rRNA), we then ﬁltered reads as follows. The
reads were mapped separately, using NovoAlign, to three indexes:
(i) the mm10 genome, (ii) mm10 protein-coding transcripts (cDNAs),
and (iii) pseudochromosomes assembled from RepeatMasker re-
peats, the ribosomal DNA repeat (Grozdanov et al, 2003) and
gencode.vM9 small noncoding RNAs (e.g., miRNA, snoRNA, snRNA,
and rRNA). “Nonrepeat” reads were then deﬁned as those that
mapped better to the mm10 genome or cDNAs than to any of the
repeat RNAs or small noncoding RNAs.
To examine reads arising from Mtr4-bound RNA fragments that
contain non-genome-encoded oligonucleotide tails, only those
reads for which a 39 adapter (7 nt or longer) could be detected using
Trimmomatic were retained. The reads were then ﬁltered to retain
only those for which each position has a FASTQ quality score of at
least 30, and PRINSEQ was used to ﬁlter out homopolymers or
dinucleotide-rich sequences. Identical sequences (including the
inline 59 UMI) were then collapsed to remove PCR duplicates.
Identifying reads with non-genome-encoded oligonucleotide tails
Reads for which 39 adapters were detected and removed (described
in the CRAC and NET-seq sequencing read preprocessing and ﬁl-
tering section) were mapped to mm10 using BLASTn (version: ncbi-
blast-2.5.0). Any non-mapping region at the 39 end of the read was
recorded as a non-genome-encoded tail, removed from the 39 end
of the read, and annotated at the end of the read name. To exclude
reads mapping to repeats, reads were processed as described
above, resulting in a set of “nonrepeat” reads. As some of the non-
genome-encoded tails might in fact arise from spliced RNA frag-
ments, any reads mapping better to spliced mRNAs than to the
genome were also excluded.
To examine the genomic sequence composition around the 39
end of RNA fragments with non-genome-encoded oligo(A) tails,
reads with A≥2 tails were selected, the genome encoded portion
mapped to the genome using bowtie2, and the 39 end position
recorded. Reads were then ﬁltered depending on whether they
mapped to introns, PROMPT regions (the 1-kb region downstream of
a lincRNA or mRNA TSS, in the sense direction), or antisense
PROMPT regions (the 1-kb upstream of a lincRNA or mRNA TSS, in
the antisense direction). For genes where more than one A-tailed
read mapped to a region, one read was selected at random. The
genomic sequence was then extracted for 201-nt windows centred
on each of the selected 39 end positions, and the average nucle-
otide composition calculated at each position along the PROMPT,
antisense PROMPT, and intronic windows. To distinguish intronic
A-tailed reads aligning precisely to the 39 end of the intron from
those mapping elsewhere in the intron, we split the intronic reads
into those ending with AG versus those that do not.
CRAC and NET-seq metaplots
For pre-mRNA metaplots, “nonrepeat” reads were mapped to the
genome (mm10) using bowtie2 (mode: -sensitive). The midpoint of
each mapped read was taken and counted for 5-nt bins ﬂanking
each end of exons from protein-coding genes. For each gene, the
Appris principal 1 isoform was used (selecting one at random
where >1 existed for a single gene). For each transcript, bin totals
were divided by the maximum bin total, and then bin averages
calculated for each bin across all transcripts. For metaplots of 2-kb
regions centred on protein-coding gene TSSes, the same procedure
was used, except the bins were 10-nt wide.
Calculating Mtr4:PolII ratios for PROMPTs, exons, and introns
For this analysis, the set of lincRNA and mRNA annotations in-
cluding de novo deﬁned Cufﬂinks features was used. For each
transcript, the primary TSS was identiﬁed using the following
criteria.
(i) The TSS is within 0.5 kb of an H3K4me3 ChIP-seq peak deﬁned
by MACS2.
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(ii) The sense PROMPT region for the TSS has a moderate NET-
seq signal (20 counts).
(iii) The sense PROMPT region has higher NET-seq signal than
other TSSes of the same gene.
(iv) There are no other 1-kb regions in the same gene that are not
annotated as a TSS but that have > twofold more NET-seq
signal than the 1-kb PROMPT region (this criterion excludes
genes where the “real” TSS might not be annotated).
(v) The RNA-seq signal in the 2-kb sense direction from the TSS
must be at least 1.5× that of the RNA-seq signal in the up-
stream 2-kb antisense region (to remove transcripts that are
upstream antisense PROMPTs).
(vi) The transcript must not overlap snoRNAs.
(vii) The transcript must be >2 kb, with at least 1 kb of exonic
sequence.
For the transcripts corresponding to the selected TSSes, the
transcript region was divided into the following categories:
(i) sense PROMPT region: 1-kb downstream of the TSS, sense
direction,
(ii) antisense PROMPT region: 1-kb upstream of the TSS, antisense
direction,
(iii) exons: all exonic regions outside of the sense PROMPT region,
and
(iv) introns.
CRAC and NET-seq reads that do not map to repeats (see the
CRAC and NET-seq sequencing read preprocessing and ﬁltering
section) were then counted for each of these features, for each
selected lincRNA and mRNA transcript, and the Mtr4:PolII ratio
calculated.
Bulk RNA-seq analysis (ribozyme and deletion cell lines, and half-
life analysis)
Sequencing reads were aligned to the genome using gsnap, pro-
viding splice sites from the combined reference ﬁle (excluding de
novo lincRNAs) and only retaining uniquely mapping reads. The
reads were then counted either for Ensembl features or for the
combined reference ﬁle (including de novo lincRNAs), using htseq-
count (mode = union). For PCA, datasets were normalised using the
estimateSizeFactorsForMatrix function in DESeq2, and batches of
samples sequenced at different times corrected by centring the
means in log space. For analysis of gene expression adjacent to
lincRNA loci, the datasets were similarly normalised and batch-
corrected by centring the median in log space. Expression changes
were evaluated for signiﬁcance using a Monte Carlo simulation. For
transcriptome-wide differential expression analysis, the Wald test
in DESeq2 was used (padj < 0.01), including the sequencing data as
a factor in the design matrix. To identify genes changing in ex-
pression in the Macfarlan G9a knock out dataset, G9a knock-out
and wild-type RNA-seq data were aligned with gsnap, reads
counted for Ensembl features, datasets normalised using the
estimateSizeFactorsForMatrix function in DESeq2, and the fold
change calculated (adding a pseudocount of eight to each mea-
surement). Genes with a fold change of >1.5 were recorded as up-
regulated. The signiﬁcance of the overlap between up-regulated
genes in our dataset and the Macfarlan dataset was assessed using
a chi-squared test.
For RNA half-life analysis, counts for lincRNAs and mRNAs in the
combined reference ﬁle (including de novo lincRNAs) were used.
Datasets were normalised using size factors calculated for the ERCC
RNA spikes (mean count > 50) using the estimateSizeFactorsForMatrix
method in DESeq2. To calculate half-lives, the following formula based
onmedian counts at time = 0 and time = 240 was used: t1/2 = (240 × log
(2))/log(med.ncounts.0/med.ncounts.240).
Data Availability
All sequencing data have been deposited in the Gene Expression
Omnibus, accession code: GSE107493.
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